Profile

MBChB, University of Aberdeen
MSc, University of Edinburgh




Open-label dose-ranging study of prasugrel in pediatric patients with sickle cell disease Protocol # H7T-MC-TACX
10/01/2011 - 08/01/2012 (PI)
Eli Lilly and Company


Open-label dose-ranging study of prasugrel in pediatric patients with sickle cell disease Protocol # H7T-MC-TACX
10/01/2011 - 08/01/2012 (PI of Sub-Project / SP)
Eli Lilly and Company





Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Magge H, Sprinz P, Adams WG, Drainoni ML, Meyers A. Zinc protoporphyrin and iron deficiency screening: trends and therapeutic response in an urban pediatric center. JAMA Pediatr. 2013 Apr; 167(4):361-7.View Related Profiles. PMID: 23420187; DOI: 10.1001/jamapediatrics.2013.751;.
     
  2. Chawla A, Sprinz PG, Welch J, Heeney M, Usmani N, Pashankar F, Kavanagh P. Weight status of children with sickle cell disease. Pediatrics. 2013 Apr; 131(4):e1168-73.View Related Profiles. PMID: 23460681; DOI: 10.1542/peds.2012-2225;.
     
  3. Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ. Management of children with sickle cell disease: a comprehensive review of the literature. Pediatrics. 2011 Dec; 128(6):e1552-74.View Related Profiles. PMID: 22123880; DOI: 10.1542/peds.2010-3686;.
     
  4. Hawkins F, Ebel N, Sorescu GP, McMahon L, Sprinz P, Klings ES. Keeping it in the family: three relatives with HbSC disease and simultaneous acute pulmonary emboli. Am J Hematol. 2012 Jan; 87(1):101-4.View Related Profiles. PMID: 21953788; DOI: 10.1002/ajh.22177;.
     
  5. Wang CJ, Kavanagh PL, Little AA, Holliman JB, Sprinz PG. Quality-of-care indicators for children with sickle cell disease. Pediatrics. 2011 Sep; 128(3):484-93.View Related Profiles. PMID: 21844055; DOI: 10.1542/peds.2010-1791;.
     
  6. Sobota A, Neufeld EJ, Sprinz P, Heeney MM. Transition from pediatric to adult care for sickle cell disease: results of a survey of pediatric providers. Am J Hematol. 2011 Jun; 86(6):512-5.View Related Profiles. PMID: 21594889; DOI: 10.1002/ajh.22016;.
     
  7. Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med. 2010 Apr; 38(4 Suppl):S550-6.View Related Profiles. PMID: 20331957; DOI: 10.1016/j.amepre.2010.01.004;.
     
  8. Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer. 2009 Oct; 53(4):642-6.View Related Profiles. PMID: 19492318; DOI: 10.1002/pbc.22069;.
     
  9. Goldberg SA, O'Connor SC, Sprinz PG. Prostaglandin inhibitors in the treatment of single-system Langerhans cell histiocytosis: pharmacologic rationale and report of two cases. J Pediatr Hematol Oncol. 2008 Oct; 30(10):778-80. PMID: 19011480; DOI: 10.1097/MPH.0b013e318184e6b3;.
     
  10. Kavanagh PL, Wang CJ, Therrell BL, Sprinz PG, Bauchner H. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states. Am J Med Genet C Semin Med Genet. 2008 Feb 15; 148C(1):15-22.View Related Profiles. PMID: 18200513; DOI: 10.1002/ajmg.c.30160;.
     
Showing 10 of 20 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 4 publications over 3 distinct years, with a maximum of 2 publications in 1988

YearPublications
19871
19882
20011
Contact for Mentoring: